Operator: [Operator Instructions] The next question is from Josh Raskin with Nephron Research. Please go ahead.
Josh Raskin: Hi, thanks. Good morning. Just wanted to touch a little bit on sort of same-store revenue and just sort of overall same-store business. So you guys mentioned the weakness in the first quarter. And then in 2Q, it was up at 9% sort of back down to that 5% number here. Is this more of a – do you think we’re kind of through the normal path and that 5% is kind of a number to think about as we go through 2024? And then maybe just some color on what’s created some of the volatility this year?
Kevin Hammons: So thanks, Josh. I do think kind of that 5%, as we think about our longer-term, medium-term goals of delivering kind of mid-single-digit net revenue growth, that 5% fits right into that, and that’s where I would expect kind of same-store revenue growth to be kind of as we look – go into next year and that’s what we would target. In terms of some of the volatility, part of that is – was due to the comp. We had significant softness in the second quarter of 2022 kind of as – you can go back to April 2022 and restrictions on masking and so forth were lifted, restrictions on travel were lifted. And that’s when we saw the real kind of exodus in some respects from the healthcare system, people are going about doing other things and not coming into the healthcare systems since they were free to move about and return to more normal behaviors.
So we had a little easier comp in the second quarter in terms of that volume. So I think that contributed a little bit to the kind of percentage growth. But as I think about, again, sequentially we continue to grow. So stepping over that in terms of admissions, adjusted admissions into the third quarter, very helpful. The normal seasonality on surgeries, not unexpected now that we’re seeing were kind of getting back to more normal behaviors and the recovery is setting in.
Josh Raskin: Got you. That’s helpful. And then just on payer mix. I know you mentioned it to A.J.’s question, but you can sort of talk a little bit, Medicare was down a little bit. So again, is it just sort of moving parts on rate that impacted self-pay and some other stuff that kind of drove Medicare down? Or was there anything in there?
Kevin Hammons: The Medicare – the fee-for-service was down, but Medicare Advantage was up year-over-year. So that’s maybe just a shift of that Medicare’s population out of the traditional fee-for-service programs into MA programs. Commercial business was up year-over-year and then kind of Medicaid and self-pay were relatively flat.
Josh Raskin: Okay, thanks.
Operator: This concludes our question-and-answer session. I would like to turn the conference back over to Tim Hingtgen for any closing remarks.
Tim Hingtgen: Thank you, Gary. I want to close by expressing my appreciation for healthcare workers across CHS and across the nation. I remind it daily about how much we rely on and appreciate those who have devoted themselves to healthcare careers. And I just want to say I’m very proud of our healthcare workforce. As always, if you have additional questions, you can reach us at (615) 465-7000. Thank you, and have a great day.
Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.
